Procept Biorobotics
PRCT
127 hedge funds and large institutions have $1.46B invested in Procept Biorobotics in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 64 increasing their positions, 27 reducing their positions, and 14 closing their positions.
145% more call options, than puts
Call options by funds: $9.63M | Put options by funds: $3.93M
137% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 27
57% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 14
15% more capital invested
Capital invested by funds: $1.27B → $1.46B (+$189M)
9.54% more ownership
Funds ownership: 79.98% → 89.52% (+9.5%)
6% more funds holding
Funds holding: 120 → 127 (+7)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$53.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$21.8M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$21.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$10.9M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$10.4M |
| 3 |
ACM
Atika Capital Management
New York
|
-$4.94M |
| 4 |
TOTUOP
Trustees of The University of Pennsylvania
Philaldelphia,
Pennsylvania
|
-$3.21M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$2.18M |
PRCT Hedge Fund Activity: Q3 2023 in Review
127 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q3 2023, worth a combined $1.46B — up 15% from $1.27B a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new PRCT positions and 14 closed out — a net gain of 8 holders — while 64 added to existing stakes and 27 trimmed.
The largest buyer was Champlain Investment Partners, opening a new position worth an estimated $53.5M. The largest seller was Millennium Management, exiting entirely with an estimated $10.9M sold.
- 127 institutional investors held Procept Biorobotics (PRCT) as of Q3 2023, up from 120 in Q2 2023.
- Funds reported $1.46B of Procept Biorobotics stock for Q3 2023, up 15% quarter-over-quarter.
- 22 funds opened new Procept Biorobotics positions in Q3 2023 and 14 closed out, a net change of +8 holders.
- The largest Procept Biorobotics buyer in Q3 2023 was Champlain Investment Partners, an estimated $53.5M added.
- The largest Procept Biorobotics seller in Q3 2023 was Millennium Management, an estimated $10.9M sold.
Based on aggregated 13F filings for Q3 2023.